Vanguard Personalized Indexing Management LLC Sells 409 Shares of The Clorox Company (NYSE:CLX)

Vanguard Personalized Indexing Management LLC trimmed its position in The Clorox Company (NYSE:CLXFree Report) by 4.7% in the 4th quarter, HoldingsChannel reports. The fund owned 8,298 shares of the company’s stock after selling 409 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Clorox were worth $1,183,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. First National Bank of Mount Dora Trust Investment Services lifted its holdings in Clorox by 3.2% in the 4th quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock worth $322,000 after purchasing an additional 71 shares in the last quarter. Modera Wealth Management LLC boosted its position in shares of Clorox by 1.4% during the third quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock worth $672,000 after acquiring an additional 71 shares during the last quarter. Czech National Bank boosted its position in shares of Clorox by 0.3% during the fourth quarter. Czech National Bank now owns 21,718 shares of the company’s stock worth $3,097,000 after acquiring an additional 71 shares during the last quarter. Global Retirement Partners LLC grew its stake in Clorox by 7.2% during the fourth quarter. Global Retirement Partners LLC now owns 1,089 shares of the company’s stock valued at $156,000 after acquiring an additional 73 shares in the last quarter. Finally, West Branch Capital LLC increased its holdings in Clorox by 9.3% in the 4th quarter. West Branch Capital LLC now owns 903 shares of the company’s stock valued at $129,000 after acquiring an additional 77 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on CLX. Jefferies Financial Group upgraded Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective for the company in a research report on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft cut their price target on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. Morgan Stanley reaffirmed an “equal weight” rating and set a $160.00 price objective on shares of Clorox in a report on Tuesday, March 26th. The Goldman Sachs Group assumed coverage on shares of Clorox in a report on Friday, March 1st. They issued a “sell” rating and a $140.00 target price for the company. Finally, Barclays decreased their price target on shares of Clorox from $136.00 to $132.00 and set an “underweight” rating on the stock in a research note on Thursday, May 2nd. Four equities research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company. Based on data from MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus price target of $146.43.

Check Out Our Latest Analysis on CLX

Clorox Price Performance

CLX stock opened at $135.62 on Friday. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.14. The stock has a market cap of $16.84 billion, a PE ratio of 70.27, a P/E/G ratio of 2.09 and a beta of 0.44. The company has a 50-day moving average price of $145.93 and a 200 day moving average price of $144.60.

Clorox (NYSE:CLXGet Free Report) last announced its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.87 billion. During the same quarter in the previous year, the business earned $1.51 earnings per share. The company’s revenue for the quarter was down 5.3% compared to the same quarter last year. Equities research analysts anticipate that The Clorox Company will post 5.83 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th were given a dividend of $1.20 per share. The ex-dividend date of this dividend was Tuesday, April 23rd. This represents a $4.80 annualized dividend and a dividend yield of 3.54%. Clorox’s dividend payout ratio (DPR) is 248.71%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.